Prospective, Open-label, Non-comparative, Multicenter Study for the Secondary Prophylaxis of Invasive Fungal Infections (IFI) with Voriconazole in Patients with Allogeneic Stem Cell Transplants
Latest Information Update: 06 Sep 2021
At a glance
- Drugs Voriconazole (Primary) ; Voriconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 04 Sep 2021 Status changed from recruiting to completed.
- 05 Sep 2019 New trial record